From: The risk factors associated with COVID-19-Related death among patients with end‐stage renal disease
Characteristics | ESRD N = 74 | Non-ESRD N = 446 | P-value |
---|---|---|---|
Age (year), Mean (SD) | 63.2 (15.1) | 60.1 (18.7) | 0.167 |
Age ≥ 65 years, % (N) | 52.7% (39) | 42.8% (191) | 0.113 |
Gender Male, % (N) | 68.9% (51) | 45.3% (202) | < 0.001 |
Symptoms, % (N) | |||
Caught | 37.1% (27) | 45.3% (202) | 0.224 |
Fever | 40.3% (30) | 35.7% (159) | 0.473 |
Shortness of breath | 62.9% (46) | 59.0% (263) | 0.554 |
Tiredness | 21.0 % (15) | 26.2% (117) | 0.373 |
Being Ventilated on admission% (N) | 28.4% (21) | 9.2% (41) | <0.001 |
O2 saturation <93% % (N) | 56.8% (42) | 53.6% (239) | 0.612 |
Lack of consciousness | 16.1% (12) | 7.8% (35) | 0.032 |
Comorbidities | |||
HTN | 55.4% (41) | 24.4% (109) | <0.001 |
DM | 47.3% (35) | 20.2% (90) | <0.001 |
CVD | 29.7% (22) | 17.3% (77) | 0.011 |
Other comorbiditiesa | 10.8% (10) | 9.4% (42) | 0.706 |
Number of comorbidities | |||
No comorbidity | 21.6% (16) | 56.5% (252) | <0.001 |
1 | 29.7% (22) | 22.6% (101) | |
2 | 33.8% (25) | 13.2% (59) | |
≥ 3 | 14.9% (11) | 7.6% (34) | |
Length of the hospital stay (days), Median (IQR) | 2 (0-5) | 3 (1-6) | 0.298 |
Time to the death (days) Median (IQR) | 6 (1-12) | 5 (1-13) | 0.880 |